• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL SJM TRIFECTA VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL SJM TRIFECTA VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Catalog Number UNK SJM TRIFECTA VALVE
Device Problem Patient-Device Incompatibility (2682)
Patient Problems Arrhythmia (1721); Atrial Fibrillation (1729); Stroke/CVA (1770); Endocarditis (1834); Unspecified Infection (1930); Myocardial Infarction (1969); Pleural Effusion (2010); Pericardial Effusion (3271); Heart Block (4444)
Event Date 01/01/2017
Event Type  Death  
Manufacturer Narrative
Literature article: an analysis of early results after valve replacement in isolated aortic valve stenosis by using sutureless vs.Stented bioprostheses: a single-center middle-income country experience.Summarized patient outcomes/complications of an analysis of early results after valve replacement in isolated aortic valve stenosis by using sutureless vs.Stented bioprostheses: a single-center middle-income country experience were reported in a research article in a subject population with multiple co-morbidities including diabetes mellitus, hypertension, peripheral vascular disease, chronic kidney disease, prior stroke, smoking, aortic stenosis (angina, dyspnea, syncope).Some of the complications reported were death, infection, pleural effusion, pericardial effusion, stroke, atrial fibrillation, heart block, pacemaker implant (surgical intervention), myocardial infarction, bacterial endocarditis of prosthesis, arrhythmia, valve reoperation (re-hospitalization) these complications are anticipated for the procedure and subject population.A more comprehensive assessment could not be performed as the event was non-contemporaneously reported through a literature review and no device or individual patient information was received for analysis.
 
Event Description
The article, ¿an analysis of early results after valve replacement in isolated aortic valve stenosis by using sutureless vs.Stented bioprostheses: a single-center middle-income country experience¿, was reviewed.The article presented a retrospective single center experience to compare the survival of people with isolated severe aortic stenosis after the implantation of sutureless and stented bioprostheses in a tertiary referral center in serbia.Devices included in this study were st jude epic, st jude trifecta, sorin crown, and perceval.The article concluded that predictors of all-cause mortality over a median of 2 years of follow-up were older age, having a higher preoperative euroscore ii, having a stroke over the follow-up and having valve-related complications.Survival after bioprostheses implantation should be monitored long-term to ensure optimum postoperative outcomes.[the primary author was marko kaitovic, cardiac surgery department, institute for cardiovascular diseases ¿dedinje¿, 11040 belgrade, serbia.The corresponding author was tatjana gazibara, institute of epidemiology, faculty of medicine, university of belgrade, 11000 belgrade, serbia, with corresponding email: tatjana.Gazibara@med.Bg.Ac.Rs].The time frame of the study was from 2017 to 1 july 2021.A total of 339 patients were included in this study, of which 183 patients received an epic valve and 10 received a trifecta valve (total % = 67.3%).The average age was 72.5 years (stented bioprosthesis=72.8, sutureless=72.1) and average age was gender was male (stented bioprosthesis=150, sutureless=33).Comorbidities included were diabetes mellitus, hypertension, peripheral vascular disease, chronic kidney disease, prior stroke, smoking, aortic stenosis (angina, dyspnea, syncope).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SJM TRIFECTA VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ST. JUDE MEDICAL #3014918977
edificio #44 calle 0, ave. 2
el coyol alajuela 1897- 4050
CS   1897-4050
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key17647277
MDR Text Key322240542
Report Number2135147-2023-03759
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
PMA/PMN Number
P100029
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature,Health Professional
Reporter Occupation Physician
Type of Report Initial
Report Date 08/29/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/29/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNK SJM TRIFECTA VALVE
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received08/24/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Life Threatening; Death; Required Intervention; Disability;
-
-